This study will explore potential users' preferences regarding HIV prevention products; quantify the importance of product attributes; and predict the uptake of products to inform estimates of their potential impact on the HIV epidemic in South Africa. We consider preferences for oral pre-exposure prophylaxis; a vaginal microbicide gel; a long-acting vaginal ring; a SILCS diaphragm used in concert with gel; and a long-acting ARV-based injectable.
Authors: Quaife, M., Eakle, R., Cabrera, M., Vickerman, P., Tsepe, M., Cianci, F., et al.